792 followers
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedi... - PubMed - NCBI https://t.co/Tcyq0SFeGL
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedi... - PubMed - NCBI https://t.co/Tcyq0SFeGL
Could low-dose carvedilol prevent anthracycline-related left ventricular remodeling in childhood cancer survivors https://t.co/34uvUKMJ0B